Fresenius | FRE - Cost Of Sales


Fresenius reported EUR4.4B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Akzo Nobel EUR 1.5B 95M Jun/2026
Alcon AG USD 1.18B 26M Mar/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
BASF EUR 12.87B 1.01B Jun/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
DaVita Healthcare Partners USD 2.52B 76.13M Mar/2026
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 16.41B 114M Mar/2026
Essilor EUR 5.55B 505M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Getinge SEK 3.97B 2.05B Jun/2026
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 2.07B 192M Jun/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
GRIFOLS EUR 1.17B 90M Jun/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.71B 251M Jun/2026
Philips EUR 2.21B 70M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
RWE EUR 3.21B 397M Mar/2026
Sanofi EUR 3.02B 656M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026